Companies/Ayurcann Holdings Corp.

Company profile

Ayurcann Holdings Corp.

OTC: AYURF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Pickering, ONReports USD

#531 of 1,394 Healthcare companies by revenue67th-percentile growth

EA Score

57C

FH 57DQ —GM 70SS 32

v0.1 · 45/100 weight · provisional

↑ 3-yr revenue growth, operating margin · ↓ workforce scale, market scale

Methodology →

Revenue TTM

$20.6M

Rev growth YoY (TTM)

+41.8%

Net income (FY)

-$2.5M

Employees

Market cap

$408.9k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$22.3M31.1M CAD2025

Net income-$2.5M-3.5M CAD2025

Operating income-$2.0M-2.8M CAD2025

Total assets$6.8M9.3M CAD2025

Liabilities$8.4M11.5M CAD2025

Equity-$1.6M-2.2M CAD2025

Revenue trend

FY2018 – FY2025 · USD

FY18

FY19

FY20

$6.0M

FY21

$7.4M

FY22

$9.3M

FY23

$18.6M

FY24

$22.3M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Ayurcann Holdings Corp. booked $22.3M in FY2025 revenue, growing 20% year over year — faster than most Healthcare companies we track, at a -11.2% net margin.

Peers · Healthcare

Alternative Energy Partners, Inc.——Helix BioMedix, Inc.56C Protagenic Therapeutics, Inc.——Certive Solutions Inc.——

Key facts

CEOIgal Sudman

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersPickering, ON

ExchangeOTC: AYURF

Employees5

IPO date2014-11-21

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.